Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

172 Results Found

Member

AHA 340B Advocacy Alliance Bulletin - February 25, 2026

The Health Resources and Services Administration today said it will extend the deadline to April 20 to receive comments.
340B Drug Pricing Program
Member

AHA 340 Advocacy Alliance Bulletin - February 23, 2026

Hospitals should submit letters to HRSA by March 19.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance Bulletin - February 19, 2026

The American Hospital Association 340B Advocacy Alliance Bulletin for February 19, 2026.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance Bulletin - February 17, 2026

The AHA Feb. 19 at 3 p.m. ET will host a call to discuss the Department of Health Human Services’ request for information on a new 340B rebate model program.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance -

The Department of Health and Human Services today issued a request for information on a new 340B rebate model program.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance Bulletin - February 10, 2026

The AHA has submitted a statement for the hearing and issued a Member Advisory containing several resources to assist hospitals and health systems in discussing these issues.
340B Drug Pricing Program
Member

340B Advocacy Alliance Bulletin - February 9, 2026

New administrative process begins on 340B rebate models; hospitals should begin working on comment letters now.
340B Drug Pricing Program
Member

340B Advocacy Alliance Bulletin - February 5, 2026

Blog: 340B is a Solution, not a Threat to Health Care Affordability
340B Drug Pricing Program
Member

340B Advocacy Alliance Bulletin - January 26, 2026

AHA urges HRSA to stop Eli Lilly’s new claims-data submission policy on 340B hospitals from going into effect; hospitals urged to submit their own letters to HRSA and use AHA letter as a guide.
340B Drug Pricing Program
Member

AHA 340B Advocacy Alliance Bulletin - January 12, 2026

Several health care groups, including the AHA, today told the Centers for Medicare & Medicaid Services it is wrong to tell hospitals and health systems they “are to” complete the agency’s Outpatient Prospective Payment System Drug Acquisition Cost Survey and urged CMS to correct an FAQ issued on the issue.
340B Drug Pricing Program, Outpatient Prospective Payment Systems (OPPS)